Evidence map›Paper›PMID 41177559›Full record

ArticleBMJ paediatrics open2025

Continuity of paediatric care for adolescents and young adults with leukaemia: a single-centre experience from China.

Kefei Wu, Wensi Qian, Kunlin Pei, Zhuo Wang, Changcheng Chen, Shuhong Shen, Hao Zhang, Jiajun Yuan, Yao Yao, Wenting Hu

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ paediatrics open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kefei Wu *Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0003-0599-1272
Wensi Qian *Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Kunlin PeiKey Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhuo WangKey Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Changcheng ChenKey Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shuhong ShenKey Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hao ZhangResearch Division for Health Administration and Smart Healthcare, Child Health Advocacy Institute, China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai, China.
Jiajun YuanResearch Division for Health Administration and Smart Healthcare, Child Health Advocacy Institute, China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai, China huwenting_scmc@163.com yyxy@suda.edu.cn yuanjiajun@shsmu.edu.cn.
Yao YaoNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China huwenting_scmc@163.com yyxy@suda.edu.cn yuanjiajun@shsmu.edu.cn.
Wenting HuKey Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China huwenting_scmc@163.com yyxy@suda.edu.cn yuanjiajun@shsmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adolescents and young adults (AYAs) with leukaemia represent a unique population but face fragmented care between paediatric and adult systems. A retrospective study of AYA patients (≥14 years old) with leukaemia treated at Shanghai Children's Medical Center between September 2023 and March 2025 found acute lymphoblastic leukaemia (ALL) was predominant (152/189). AYA ALL patients showed a higher prevalence of high-risk subtypes like T-ALL and

Indexed as

Continuity of Patient CareLeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChinaFemaleHumansMaleRetrospective StudiesYoung AdultAdolescent Health

Identifiers

PMID41177559
PMCPMC12581056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.